Protocol for the examination of specimens from patients with primary carcinomas of the colon and rectum

Archives of Pathology and Laboratory Medicine

Volumn 132, Issue 7, 2008, Pages 1182-1193

  Washington, Mary Kay ^a   Berlin, Jordan ^a   Branton, Philip A ^b   Burgart, Lawrence J ^c   Carter, David K ^d   Fitzgibbons, Patrick L ^e   Frankel, Wendy L ^f   Jessup, John M ^g   Kakar, Sanjay ^h   Minsky, Bruce ⁱ   Nakhleh, Raouf E ^j   Compton, Carolyn C ^g  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b INOVA FAIRFAX HOSPITAL   (United States)

^c ABBOTT NORTHWESTERN HOSPITAL   (United States)

^d Duluth Clinic   (United States)

^e ST JUDE MEDICAL CENTER   (United States)

^f THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^g NATIONAL CANCER INSTITUTE   (United States)

^h VETERANS AFFAIRS MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF CHICAGO   (United States)

^j St' Luke's Hospital   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL;

CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER GRADING; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; CANCER TISSUE; CLINICAL PROTOCOL; COLON CARCINOMA; COLON POLYP; COLON SURGERY; COLORECTAL CARCINOMA; DIAGNOSTIC VALUE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; INVASIVE CARCINOMA; LYMPH NODE METASTASIS; MEDICAL EXAMINATION; METASTASIS; MICROMETASTASIS; MUTATIONAL ANALYSIS; POLYPECTOMY; RECTUM CARCINOMA; RECTUM POLYP; RECTUM SURGERY; REVIEW; SURGICAL TECHNIQUE; TUMOR LOCALIZATION; TUMOR VASCULARIZATION; WORLD HEALTH ORGANIZATION;

CLINICAL PROTOCOLS; COLORECTAL NEOPLASMS; HUMANS; NEOPLASM STAGING; PATHOLOGY, SURGICAL;

EID: 46849103615     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Greene FL, Page DL, Fleming ID, et al, eds. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer; 2002.
2. Greene FL, Compton CC, Fritz AG, Shah J, Winchester DP, eds. AJCC Cancer Staging Atlas. New York, NY: Springer; 2006.
3. Fielding LP, Arsenault PA, Chapuis PH, et al. Clinicopathological staging for colorectal cancer: an International Documentation System (IDS) and an International Comprehensive Terminology (ICAT). J Gastroenterol Hepatol. 1991;6:325-344.
4. Wittekind C, Henson DE, Hutter RVP, Sobin LH, eds. TNM Supplement. A Commentary on Uniform Use. 2nd ed. New York, NY: Wiley-Liss; 2001.
5. Hamilton SR, Vogelstein B, Kudo S, et al. Carcinoma of the colon and rectum. In: Hamilton SR, Aaltonen LA, eds. Pathology and Genetics of Tumours of the Digestive System. Lyon, France: IARC Press; 2000:103-143. World Health Organization Classification of Tumours; vol 2.
6. Kakar S, Smyrk TC. Signet ring cell carcinoma of the colorectum: correlations between microsatellite instability, clinicopathologic features, and survival. Mod Pathol. 2005;18:244-249.
7. Kang H, O'Connell JB, Maggard MA, Sack J, Ko CY. A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum. Dis Colon Rectum. 2005;48:1161-1168.
8. Bernick PE, Klimstra DS, Shia J, et al. Neuroendocrine carcinomas of the colon and rectum. Dis Colon Rectum. 2004;47:163-169.
9. Kim H, Jen J, Vogelstein B, Hamilton SR. Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am J Pathol. 1994;145:148-156.
10. Jass JR, Smyrk TC, Stewart SM, Lane MR, Lanspa SJ, Lynch HT. Pathology of hereditary non-polyposis colon cancer. Anticancer Res. 1994;14:1631-1634.
11. Wick MR, Vitsky JL, Ritter JH, Swanson PE, Mills SE. Sporadic medullary carcinoma of the colon: a clinicopathologic comparison with nonhereditary poorly differentiated enteric-type adenocarcinoma and neuroendocrine colorectal carcinoma. Am J Clin Pathol. 2005;123:56-65.
12. Jass JR, Cuzick J, Bussey HJR, Morson BC, Northover JMA, Todd IP. The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases. Histopathology. 1986;10:437-439.
13. Compton CC. Colorectal cancer. In: Gospodarowicz MK, O'Sullivan B, Sobin LH, eds. Prognostic Factors in Cancer. New York, NY: Wiley-Liss; 2006: 133-137.
14. Compton CC, Fielding LP, Burgart LJ, et al. Prognostic factors in colorectal cancer: College of American Pathologists consensus statement 1999. Arch Pathol Lab Med. 2000;124:979-994.
15. Cooper HS, Deppisch LM, Kahn EI, et al. Pathology of the malignant colorectal polyp. Hum Pathol. 1998;29:15-26.
16. Risio M, Fiocca R. Malignant adenoma: diagnosis, staging, risk factors, lymph node involvement, and problems of sampling. Tech Coloproctol. 2004;8:S253-256.
17. Chapuis PH, Dent OF, Bokey EL, Newland RC, Sinclair G. Adverse histopathological findings as a guide to patient management after curative resection of lymph node-positive cancer. Br J Surg. 2004;91:349-354.
18. Coverlizza S, Risio M, Ferrari A, Fenoglio-Preiser CM, Rossini FP. Colorectal adenomas containing invasive carcinoma: pathologic assessment of lymph node metastatic potential. Cancer. 1989;64:1937-1947.
19. Blenkinsopp W, Stewart-Brown S, Blesovsky L, Kearney G, Fielding LP. Histopathology reporting in large bowel cancer. J Clin Pathol. 1981;34:509-513.
20. Di Fabio F, Nascimbeni R, Villanacci V, et al. Prognostic variables for cancer-related survival in node-negative colorectal carcinomas. Dig Surg. 2004;21:128-133.
21. Fujita S, Shioda T, Yoshimura K, et al. Prospective evaluation of prognostic factors in patients with colorectal cancer undergoing curative resection. J Surg Oncol. 2003;84:127-131.
22. Snover DC, Jass JR, Fenoglio-Preiser C, Batts KP. Serrated polyps of the large intestine: a morphologic and molecular review of an evolving concept. Am J Clin Pathol. 2005;124:380-391.
23. Anwar MA, D'Souza F, Coulter R, Memon B, Khan IM, Memon MA. Outcome of acutely perforated colorectal cancers: experience of a single district general hospital. Surg Oncol. 2006;15:91-96.
24. Arbman G, Nilsson E, Hallböök O, Sjödahl R. Can total mesorectal excision reduce the local recurrence rate in rectal surgery? Br J Surg. 1996;83:375-379.
25. Kapiteijn E, Marijnen CAM, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345:638-646.
26. Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004;96:261-268.
27. Alexander J, Watanabe T, Wu T-T, Rashid A, Li S, Hamilton SR. Histopathologic identification of colon cancer with microsatellite instability. Am J Pathol. 2001;158:527-535.
28. Greenson JK, Bonner JD, Ben-Yzhak O, et al. Phenotype of microsatellite unstable colorectal carcinomas: well-differentiated and focally mucinous tumors and the absence of dirty necrosis correlate with microsatellite instability. Am J Surg Pathol. 2003;27:563-570.
29. Birbeck KF, Macklin CP, Tiffin NJ, et al. Rates of circumferential margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg. 2002;235:449-457.
30. Ruo L, Tickoo S, Klimstra DS, et al. Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy. Ann Surg. 2002;236:75-81.
31. Gavioli M, Luppi G, Losi L, et al. Incidence and clinical impact of sterilized disease and minimal residual disease after preoperative radiochemotherapy for rectal cancer. Dis Colon Rectum. 2005;48:1851-1857.
32. Ryan R, Gibbons D, Hyland JMP, et al. Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology. 2005;47:141-146.
33. Sobin LH, Wittekind C. UICC TNM Classification of Malignant Tumours. 6th ed. New York, NY: Wiley-Liss; 2002.
34. Shepherd N, Baxter K, Love S. The prognostic importance of peritoneal involvement in colonic cancer: a prospective evaluation. Gastroenterology. 1997;112:1096-1102.
35. George A, Primrose J, Talbot R, et al. Will Rogers revisited: prospective observational study of survival of 3592 patients with colorectal cancer according to number of nodes examined by pathologist. Br J Cancer. 2006;95:841-847.
36. Görög D, Nagy P, Péter A, Perner F. Influence of obesity on lymph node recovery from rectal resection specimens. Pathol Oncol Res. 2003;9:180-183.
37. Wijesuriya RE, Deen KI, Hewavisenthi J, Balawardana J, Perera M. Neoadjuvant therapy for rectal cancer downstages tumor but reduces lymph node harvest significantly. Surg Today. 2005;35:442-445.
38. Kim J, Huynh R, Abraham I, Kim E, Kumar R. Number of lymph nodes examined and its impact on colorectal cancer staging. Am Surg. 2006;72:902-905.
39. Cserni G, Vinh-Hung V, Burzykowski T. Is there a minimum number of lymph nodes that should be histologically assessed for a reliable nodal staging of T3N0M0 colorectal carcinomas? J Surg Oncol. 2002;81:63-69.
40. Goldstein NS. Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years: recommendations for a minimum number of recovered lymph nodes based on predictive probabilities. Am J Surg Pathol. 2002;26:179-189.
41. Singletary SE, Greene FL, Sobin LH. Classification of isolated tumor cells: clarification of the 6th edition of the American Joint Committee on Cancer Staging Manual. Cancer. 2003;90:2740-2741.